Robles, Gloria M.
HRN: 15-84-44 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/25/2023
CEFTAZIDIME 1GM (VIAL)
12/25/2023
12/31/2023
IV
2 Grams
Q 8 Hours
Cap
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes